COVID-19 vaccine development, production and regulatory oversight in African countries

Makenga, Geofrey; Booy, Robert; Oloo, Paul Ndaya; Auerbach, Joachim.
Bull. W.H.O. (Print) ; 100(10): 651-652, 2022-10-01.
Artículo en Inglés | WHOLIS | ID: who-363410

Documentos relacionados

  1. Epidemiologia dos acidentes por animais peçonhentos e a distribuição de soros: estado de arte e a situação mundial
  2. Biomedical research in france and brazil: an analysis of significant differences and ethical issues
  3. Expanding global vaccine manufacturing capacity: Strategic prioritization in small countries.
  4. SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward.
  5. Donación de sangre y prevalencia de infecciones transmitidas por la sangre en una clínica de Luanda, Angola
  6. Will people in conflict affected zones in Africa have access to COVID-19 vaccine? A case of Nigeria.
  7. Metanálise de esporotricose felina: um destaque para sua ocorrência no Brasil
  8. Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis.
  9. COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control.
  10. The experience of disproportionate supplies of COVID-19 vaccines to Africa: the need for Africa to decolonize its public health response.